Skip to content
AwardedBelgiumGoods

Framework contract for supply of Modified Vaccinia Ankara–Bavarian Nordic (MVA-BN®), a third-generation, non-replicating smallpox vaccine

Published
Published 31 October 2025

Overview

Call for tender for the supply of Modified Vaccinia Ankara–Bavarian Nordic (MVA-BN®), a third-generation, non-replicating smallpox vaccine. Framework contract for supply of 8 000 000 (eight million) doses of mpox vaccines. There are 21 contracting authorities: European Commission (HERA), AT, BE, BG, CY, DK, EE, EL, ES, FR, HR, IE, LT, LU, MT, NL, NO, PL, RS, SI, SE

Key details

Country
Belgium
Status
Awarded
Category
Goods
Procedure
Direct
Published
31 October 2025
Classification (CPV)
Pharmaceutical products

Award outcome

Award date
30 October 2025
Contract period
— → 9 October 2029
Winner
  • BAVARIAN NORDIC AS

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    31 October 2025

Contracting authority

  • European Commission, DG HERA - European Health Emergency Preparedness and Response Authority

    Procuring entity

    Brussels, Belgium

    Authority website ↗

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Framework contract for supply of Modified Vaccinia Ankara–Bavarian Nordic (MVA-BN®), a third-generation, non-replicating smallpox vaccine — won by BAVARIAN NORDIC AS — Skim